ATE218569T1 - Verbindungen zur hemmung der magensäuresekretion - Google Patents

Verbindungen zur hemmung der magensäuresekretion

Info

Publication number
ATE218569T1
ATE218569T1 AT98907306T AT98907306T ATE218569T1 AT E218569 T1 ATE218569 T1 AT E218569T1 AT 98907306 T AT98907306 T AT 98907306T AT 98907306 T AT98907306 T AT 98907306T AT E218569 T1 ATE218569 T1 AT E218569T1
Authority
AT
Austria
Prior art keywords
stomachic
inhibiting
compounds
acid secretion
secretion
Prior art date
Application number
AT98907306T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE218569T1 publication Critical patent/ATE218569T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98907306T 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion ATE218569T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (1)

Publication Number Publication Date
ATE218569T1 true ATE218569T1 (de) 2002-06-15

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907306T ATE218569T1 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion

Country Status (32)

Country Link
US (1) US6265415B1 (de)
EP (1) EP0971920B1 (de)
JP (1) JP2001512477A (de)
KR (1) KR20000075622A (de)
CN (1) CN1100056C (de)
AR (1) AR011134A1 (de)
AT (1) ATE218569T1 (de)
AU (1) AU723389B2 (de)
BR (1) BR9807457A (de)
CA (1) CA2280008A1 (de)
CZ (1) CZ291681B6 (de)
DE (1) DE69805787T2 (de)
DK (1) DK0971920T3 (de)
EE (1) EE04016B1 (de)
ES (1) ES2178169T3 (de)
HU (1) HUP0000720A3 (de)
ID (1) ID22218A (de)
IL (1) IL131122A0 (de)
IS (1) IS1901B (de)
MY (1) MY118822A (de)
NO (1) NO313009B1 (de)
NZ (1) NZ336878A (de)
PL (1) PL190379B1 (de)
PT (1) PT971920E (de)
RU (1) RU2193036C2 (de)
SE (1) SE9700661D0 (de)
SK (1) SK283903B6 (de)
TR (1) TR199902060T2 (de)
TW (1) TW568907B (de)
UA (1) UA64741C2 (de)
WO (1) WO1998037080A1 (de)
ZA (1) ZA981134B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
DE69529219T2 (de) * 1994-07-01 2003-11-06 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Helicobacter proteine und impstoffe
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2003018054A1 (en) * 2001-08-31 2003-03-06 Chiron Srl. Helicobacter pylori vaccination
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE60317529T2 (de) 2002-09-19 2008-09-25 Schering Corp. Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
RS53118B (sr) * 2003-02-26 2014-06-30 Sugen Inc. Aminoheteroaril jedinjenja kao inhibitori protein kinaze
DK1606261T3 (da) 2003-03-10 2010-01-18 Nycomed Gmbh Hidtil ukendt fremgangsmåde til fremstilling af roflumilast
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
WO2005041961A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
EP1787991B2 (de) * 2004-07-28 2020-06-24 Takeda Pharmaceutical Company Limited PYRROLO[2,3-c]PYRIDINVERBINDUNG, VERFAHREN ZU DEREN HERSTELLUNG UND ANWENDUNG
DK1784404T3 (da) 2004-09-03 2012-02-13 Yuhan Corp Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
US7642269B2 (en) 2004-09-03 2010-01-05 Yuhan Corporation Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof
PL1784402T3 (pl) 2004-09-03 2011-12-30 Yuhan Corp Pochodne pirolo[3,2-c]pirydyny oraz sposoby ich wytwarzania
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
AU2006224619B2 (en) * 2005-03-16 2012-06-07 Takeda Gmbh Taste masked dosage form containing roflumilast
PE20061110A1 (es) * 2005-03-24 2006-10-20 Glaxo Group Ltd Derivados de imidazopiridina como antagonistas de la bomba de acido (apa)
KR101146852B1 (ko) 2005-12-05 2012-05-16 화이자 프로덕츠 인크. Ｃ?ｍｅｔ／ｈｇｆｒ 억제제의 다형체
BRPI0619424B1 (pt) 2005-12-05 2022-02-08 Pfizer Products Inc Uso de inibidores c-met/hgfrs para a fabricação de medicamentos
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
CN110483499A (zh) * 2009-11-05 2019-11-22 圣母大学 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
ES2597034T3 (es) 2011-05-30 2017-01-13 Astellas Pharma Inc. Compuesto de imidazopiridina
CN104822680B (zh) * 2012-11-30 2016-10-12 安斯泰来制药株式会社 咪唑并吡啶化合物
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (de) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridinverbindungen und Verfahren zu ihrer Herstellung
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
CZ291681B6 (cs) 2003-04-16
IS5148A (is) 1999-08-05
HK1024248A1 (en) 2000-10-05
CN1100056C (zh) 2003-01-29
ZA981134B (en) 1998-08-25
IL131122A0 (en) 2001-01-28
PL190379B1 (pl) 2005-12-30
AU723389B2 (en) 2000-08-24
TW568907B (en) 2004-01-01
AR011134A1 (es) 2000-08-02
SE9700661D0 (sv) 1997-02-25
EP0971920A1 (de) 2000-01-19
PL335485A1 (en) 2000-04-25
AU6314798A (en) 1998-09-09
HUP0000720A2 (hu) 2000-10-28
CZ301499A3 (cs) 2000-02-16
EP0971920B1 (de) 2002-06-05
MX9907650A (es) 2002-12-13
EE04016B1 (et) 2003-04-15
BR9807457A (pt) 2000-04-25
TR199902060T2 (xx) 2000-02-21
SK109999A3 (en) 2000-01-18
KR20000075622A (ko) 2000-12-26
NO994078L (no) 1999-08-24
DE69805787D1 (de) 2002-07-11
EE9900367A (et) 2000-04-17
DK0971920T3 (da) 2002-09-16
ID22218A (id) 1999-09-16
SK283903B6 (sk) 2004-04-06
UA64741C2 (uk) 2004-03-15
IS1901B (is) 2003-11-20
DE69805787T2 (de) 2003-01-02
RU2193036C2 (ru) 2002-11-20
MY118822A (en) 2005-01-31
PT971920E (pt) 2002-11-29
NO994078D0 (no) 1999-08-24
US6265415B1 (en) 2001-07-24
NZ336878A (en) 2001-05-25
JP2001512477A (ja) 2001-08-21
NO313009B1 (no) 2002-07-29
ES2178169T3 (es) 2002-12-16
CN1248257A (zh) 2000-03-22
CA2280008A1 (en) 1998-08-27
HUP0000720A3 (en) 2001-01-29
WO1998037080A1 (en) 1998-08-27

Similar Documents

Publication Publication Date Title
DE69805787D1 (de) Verbindungen zur hemmung der magensäuresekretion
DE69932397D1 (de) Zusammensetzung zur äusserlichen verwendung
ATE312101T1 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen
ATE233263T1 (de) Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
IL135574A0 (en) Substituted 4-amino-thiazol-2-yl compounds as cdk inhibitors
DE69831421D1 (de) Zusammensetzungen zur nasalen verabreichung
ID26089A (id) Turunan-turunan asam hidroksamat bisiklik
ATE225792T1 (de) Neue spiroazabizyklische heterozyklische verbindungen
FI962800L (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
DE59701496D1 (de) Verfahren zur elektrochemischen Reduktion organischer Verbindungen
ATE311887T1 (de) Diphosphonsäure enthaltende zusammensetzungen
DE69942437D1 (de) Verbessertes System zur intraluminalen Bildgebung
DE69322451D1 (de) Verfahren zur Bestimmung der Batterieentladungszeit
DE69838730D1 (de) Zusammensetzung zur zahnbeschichtung
NO992853L (no) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyklylamidforbindelser
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
DE69709695T8 (de) Verfahren zur seitenzusammensetzung
NO991561D0 (no) 3-alkoksyisoksazol-4-yl-substituerte 2-aminokarboksylsyreforbindelser
DE69520055D1 (de) Verbindungen zur Hemmung der Thrombin
FI971680A0 (fi) Kaiunpoistomekanismi
DE59709665D1 (de) Verfahren zur Verzugskorrektur
ID20927A (id) Saluran ke bawah untuk senyawa pada menara proses kimia
DE69702247D1 (de) Zusammensetzung zur inhibierung der polymerisierung
EE9700131A (et) Ühendid maohappesekretsiooni inhibeerimiseks
DE60021986D1 (de) Verfahren zur Herstellung von 3-Phenyluracil-Verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee